Dr. Mona Schneider was the long-standing head of the Neuro-Ophthalmology Department at the University Eye Clinic Graz. Under her leadership, this specialized department became part of the European Reference Network (ERN-EYE) of the EU for rare eye diseases. Numerous scientific publications, national and international presentations, and global networks guarantee you diagnostics and treatment at the highest scientific level.
Neuro-ophthalmology is dedicated to visual disorders caused by diseases of the nervous system or the connection between the eye and brain. Our specialized spectrum includes:
- Strokes: We diagnose and manage complex visual field defects and eye movement disorders (such as double vision) that may occur as a result of a stroke.
- Diseases of the optic nerve head: We precisely evaluate changes to the optic nerve, whether caused by circulatory disorders (ischemia), infections, or autoimmune processes.
- Degenerative diseases of the CNS: In neurological diseases such as multiple sclerosis, ALS, or Parkinson’s disease, we monitor eye movement, optic nerve involvement, and retinal changes to detect functional loss at an early stage.
- Genetic diseases: Rare genetic causes of vision loss, such as Leber’s Hereditary Optic Neuropathy (LHON) or Optic Atrophy (OPA), are also part of our core expertise.
- Pupillary disorders: The evaluation of pupillary differences and disorders of light reaction is an essential part of our diagnostics.
Neuro-ophthalmological diseases often manifest through initially “unexplained” vision loss or complex symptoms that require profound expertise at the interface between neurology and ophthalmology.
Thanks to specialized clinical diagnostics and state-of-the-art technologies—such as high-resolution Optical Coherence Tomography (OCT) for precise measurement of the retinal nerve fiber layer—we can identify neurological damage at a very early stage. This enables timely, targeted treatment and optimal management of the disease progression.
